Sailie Bio, Inc.

New Filing
CIK: 0002145373·Biotechnology·DELAWARE·Filed: Jul 14, 2026
Total Offering

$250,000

Amount Sold

$100,000

Investors

2

First Sale

Jun 28, 2026

Offering Details

Type
Other: Simple Agreement for Future Equity (SAFE)
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
Gregory Philip Dracoulis

Company

Sailie Bio, Inc.

38 WAREHAM ST FL 3

BOSTON, MA, 02118

617-302-6644

SEC Filing

0002145373-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free